Glaukos (GKOS) Price Target Raised to $175 on iDose Outlook

Stifel has increased the price target for Glaukos (GKOS) to $175, reflecting a positive outlook for its iDose product. The adjustment suggests confidence in the product's market potential and could enhance investor sentiment. This revised target highlights Stifel's belief in growth prospects for Glaukos amid current market conditions. Such an increase may impact trading volumes and investor interest in Glaukos stock.